日度归档：2024年8月3日

haemtech Activated Protein C

发表于由

世界*实验材料供应商 Haematologic Technologies正式上海金畔生物为其中国代理， Haematologic Technologies在一直是行业的*,一直为广大科研客户提供zui为的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务，签约 Haematologic Technologies就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

 Haematologic Technologies中国代理, Haematologic Technologies上海代理， Haematologic Technologies北京代理，Haematologic Technologies广东代理， Haematologic Technologies江苏代理Haematologic Technologies湖北代理,Haematologic Technologies天津,Haematologic Technologies黑龙江代理,Haematologic Technologies内蒙古代理,Haematologic Technologies吉林代理,Haematologic Technologies福建代理,Haematologic Technologies江苏代理, Haematologic Technologies浙江代理, Haematologic Technologies四川代理,

 

Haematologic Technologies Inc. (HTI) 公司是一家专门致力于高质量的人血浆蛋白的分离和特性研究的重要生产商， 其产品非常适用于体内研究。在公司发展的第二个十年里，HTI将目光投向参与血液凝集和纤维蛋白溶解，以及骨代谢调节的蛋白的研究。HTI产品系列含有超 过100种高纯度和特异性的蛋白，包括：酶原、酶、协同因子和抑制剂，同时还提供补体系列的单克隆和多克隆抗体。另外，HTI还提供一些技术服务，如：蛋 白定制、纯化、修饰、科研合作等。

 

Activated Protein C

活化蛋白C（APC）
因子Va的失活被表示为APC的因子Va的蛋白水解失活，其中：PS =蛋白S，PCPS =磷脂囊泡（或细胞表面）和Ca ++ =钙离子。通过APC（实心箭头）（1,2）在三个特定位点处的因子Va重链（94K）的蛋白水解，导致因子Va以形成因子Vai的失活。因子Va重链中这些切割位点的位置如下：（人：R306，R506，R679）和（牛：R306，R505，R662）。辅因子分子的*灭活需要在精氨酸306位置进行切割。通过活化蛋白C在精氨酸306切割仅在膜的存在下发生，并且需要先前在精氨酸-505切割重链。由APC发生的因子Va轻链的蛋白水解仅在牛分子中发生，并且不需要灭活（虚箭头）。

 

 

 

 

 

货号：HCAPC-0080

Human Activated Protein C

 

Size 50 µg
Formulation 50% (vol/vol) Glycerol/H2O
Storage -20°C
Purity >95% by SDS-PAGE
Activity Determination Chromogenic Assay
Shelf Life (properly stored) 12 months

 

 

 

 

 

 

货号：HCAPC-DEGR 

Human Activated Protein C – DEGR (active site blocked)

 

Size 50 µg
Formulation 20 mM Tris, 150 mM NaCl, pH 7.4
Storage -80°C
Purity >95% by SDS-PAGE
Activity Determination Chromogenic Assay
Shelf Life (properly stored) 12 months

 

 

 

 

 

 

货号：BCAPC-1080 

Bovine Activated Protein C

Size 50 µg
Formulation 50% (vol/vol) Glycerol/H2O
Storage -20°C
Purity >95% by SDS-PAGE
Activity Determination Chromogenic Assay
Shelf Life (properly stored) 12 months

 

 

 

 

 

 

货号：BCAPC-DEGR 

Bovine Activated Protein C – DEGR (active site blocked)

尺寸 50μg
公式 20mM Hepes，150mM NaCl，pH 7.4
存储 -80℃下
纯度 > 95％通过SDS-PAGE
活动确定 显色测定
保质期（妥善储存） 12个月

 

 

 

 

 

 

样品凝胶信息：

凝胶 Novex 4-12％Bis-Tris
加载 人aPC，每泳道1μg
缓冲 MOPS
标准 见蓝皮书2; 肌球蛋白（191kDa），磷酸化酶B（97kDa），BSA（64kDa），谷氨酸脱氢酶（51kDa），醇脱氢酶（39kDa），碳酸酐酶（28kDa），肌红蛋白红（19kDa），溶菌酶kDa的）

 

我们公司zui大优势是强大的采购，

1：基本什么都能进口，血清，抗体，耗材，还有部分限制进口的，

2：货品全，现经营过700多个品牌，基本所有生物试剂耗材都可以进口，特别是冷偏的产品那就更有优势，

3：提供加急服务，一般1-2周到货，超过时限加急费全免

4：价格公道，绝大部分价格有优势，当然不能保证100%产品都是,因为意味着没有服务.

5：良好的信誉，大部分客户我们提供货到付款服务，客户包括清华，北大 交大 复旦，中山等100多所大学，ROCHE，阿斯利康，国药 ，fisher等500多家公司

6：我们*代理的品牌有：Antibody Research Corporation，arcticzymes，Biorelevant，AmberGen, Inc. ，clemente-associates，clodronaiposomes，Columbia Biosciences，enzyme research，Gene Bridges GmbH，Genovis，AmberGen, Inc.  Biotechnology GmbH，Haematologic Technologies HTI Haemtech，hookelabs，Immudex，Innovative Research of America，inspiralis ，List Biological Laboratories, Inc.，lumafluor，Microsurfaces，multiplicom，nanotools，Pel-Freez Biologicals，pentapharm，progen，Protein Ark，QA-Bio,Inc，QA-Bio,IncQuickZyme Biosciences，Teknova，TriLink BioTechnologies, Inc.，Zyagen Laboratories 等

7：我们还是invitrogen,qiagen,Midland BioProducts Corporationam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等知名*批发，欢迎合作。

 

MPG® Streptavidin酶试剂盒Takara

发表于由

MPG® Streptavidin
品牌 Code No. 产品名称 包装量 价格（元） 说明书 数量
Takara 6124A MPG® Streptavidin 2 ml ￥2,183 MPG® Streptavidin MPG® Streptavidin MPG® Streptavidin
收藏产品 加入购物车
 
■ 浓度
10 mg/ml (4～6 ×107 particles/ml)  
   
 
■ 制品说明
MPG® Streptavidin是多孔的磁性玻璃微粒，表面共价结合链霉亲和素。
 
■ 保存
4℃。
 
■ 组成
溶解于含0.1% BSA和0.02% NaN3* 的PBS (pH7.4) 中。
* 本制品的保存溶液中含有叠氮化钠，叠氮化钠与许多重金属反应引起爆炸，废弃时请使用大量水冲洗。
 
■ 规格
粒子大小：5 μm
孔径大小：50 nm
 
■ 用途
◇ mRNA、蛋白质和抗原的分离。
◇ DNA、RNA、DNA结合蛋白质的纯化。
◇ 差减克隆。
 
 

pMDLg pRRE载体说明书

发表于由

 pMDLg pRRE载体

型号 载体名称 出品公司 载体用途
VMA0374 pMDLg pRRE Addgene 慢病毒载体
载体描述: 

This 3rd generation LV packaging plasmid includes gag, coding for the virion main structural proteins; pol, responsible for the retrovirus-specific enzymes; and RRE, a binding site for the Rev protein which facilitates export of the RNA from the nucleus. This plasmid does not include Rev. The third generation packaging system offers maximal biosafety but is more cumbersome, as it involves the transfection of four different plasmids in the producer cells.
Example of a 3rd generation packaging combo: pMDLg/pRRE + pRSV-Rev + pMD2.G.

Please note that most Trono lab lentivectors contain a wt 5’LTR and can be packaged only using the 2nd generation packaging system （as the wt 5’LTR requires TAT for activation）.
If you wish to use the 3rd generation packaging system, you need to have a lentivector with a chimeric 5’LTR （e.g. CCL-, RRL-, etc） in which the HIV promoter is replaced with CMV or RSV, thus making it TAT-independent. The lentivectors carrying the chimeric 5’LTR can be packaged into either a 2nd or 3rd generation packaging system.

质粒图谱: 

ICELL8® cx Single-Cell System酶试剂盒Takara

发表于由

ICELL8® cx Single-Cell System
品牌 Code No. 产品名称 包装量 价格（元） 说明书 数量
Clontech 640188 ICELL8® cx Single-Cell System 1 System 询价 ICELL8® cx Single-Cell System ICELL8® cx Single-Cell System ICELL8® cx Single-Cell System
Clontech 650002 ICELL8® cx CellSelect® Software Each 询价 ICELL8® cx Single-Cell System ICELL8® cx Single-Cell System ICELL8® cx Single-Cell System
收藏产品 加入购物车
高通量、自动化、开放的单细胞分选系统
ICELL8® cx Single-Cell System
· 可在5,184-纳米孔芯片上自动完成单细胞分选过程
· 大口径喷嘴实现无细胞大小偏好的单细胞分选
· 荧光成像技术可区分单细胞、多细胞微孔，并对活细胞/死细胞
   进行分析
· 平台开放，拥有多款SMARTer NGS应用，支持定制应用
ICELL8® cx Single-Cell System
 
ICELL8 cx Single-Cell System是一款先进的集成自动化平台，它将成像功能与分注功能进行组合，可直接完成5,184-纳米孔芯片分离单细胞的全过程。该系统装配了大口径分配器，可以完成无细胞大小偏好的单细胞分离。成像功能可以对单细胞与多细胞进行区分。此外，通过使用荧光技术并结合细胞染料，还可以完成对活细胞/死细胞的分析。
完整的ICELL8 cx系统还包括ICELL8 cx Thermal Cycler、内置成像系统和ICELL8 cx CellSelect分析软件。只有通过该分析软件选择的微孔，才能进行后续操作，去除了来自多细胞孔与空细胞孔的噪声。开放、高通量的ICELL8 cx单细胞自动化系统拥有多种预验证的SMARTer NGS应用，也可以根据用户自身选择灵活地开发应用。
 
ICELL8® cx Single-Cell System ICELL8® cx Single-Cell System ICELL8® cx Single-Cell System
 
■ 应用领域
· SMART-Seq全长转录组分析
· ATAC-Seq
· T细胞受体分析和5’端差异表达
· 3’端差异表达
 
■ 文献案例
产品文献案例详情请点击：查阅文献
 
ICELL8® cx Single-Cell System
ICELL8 cx Single-Cell System
 
ICELL8® cx Single-Cell System ICELL8® cx Single-Cell System
芯片分注
 芯片成像
 
■ ICELL8 cx规格
  类别   规格
  电源   120VAC/60 Hz线路：4条120V，15或20A电路
  220-240VAC/50 Hz线路：4个10A插座
  100VAC/50-60 Hz线路：4个15A插座
  大小   计算机：18 cm×37 cm×44 cm
  ICELL8 cx组件：107 cm×56 cm×57 cm
  工作台空间   ICELL8 cx组件和计算机所需工作台空间：180 cm×75 cm×60 cm
  Note：工作台必须能够承受91 kg的重量
  重量   91 kg
 
 
产品详情请点击：ICELL8® cx Single-Cell System
 
更多相关制品信息请点击：ICELL8® cx Single-Cell System
 
 
■ 视频资料
 

JCRB细胞库 JCRB0086

发表于由

JCRB细胞库，正在收集各种人类和动物培养细胞，包括癌症和转基因细胞。细胞资源被分配给日本乃至*的研究人员。这些细胞通过测试微生物污染，病毒污染和交叉培养物污染而获得全面认证。一些细胞的特征是核型分析和/或细胞表面标记。我们与世界上其他主要的细胞库合作，正在开发细胞培养和质量控制方法，以支持药物科学医学的基础研究。

 

 

恭喜上海金畔生物cellbank 细胞报关，顺利通关！

JCRB细胞库  JCRB0086 [TALL-1]

接受日期： 1986年5月15日
动物： 人的
性别和年龄： 男：28岁
科学名称： 智人 智人
病历： 急性淋巴细胞白血病
分类： 瘤
组织准备： 骨髓
肿瘤起源： 骨髓
开始细胞培养的日期： 05/16/86
细胞的历史： 三宅一生=> NIHS（JCRB）
介质： 含10％胎牛血清的RPMI1640培养基
通道方法： 稀释。
CO 2浓度： 5％
单元号 通过时： 5×10 ^ 5细胞/ ml
遗传学： T细胞
寿命： 无穷
形态学： 淋巴细胞样
特点： T细胞淋巴细胞白血病。模式= 95-101
小区ID数据： 可用的
DNA谱（STR）： D5S818：9,12 
D13S317：8,9 
D7S820：10,11 
D16S539：9,10 
VWA：17,19 
TH01：7,9 
Amelogenin：X，Y 
TPOX：8,11 
CSF1PO：11,13
检测到的病毒DNA： CMV（-），EBV（-），HHV6（-），HHV7（-），BKV（-），JCV（-），ADV（-），parvoB19（-），HBV（-），HTLV1（-）， HTLV2（-），HIV1（-），HIV2（-），HPV18（nt）[-/阴性，+ /阳性，nt /未测试]- 说明
建立者 Hiraki,S.
存入者 Miyoshi,I.
单元库： NIHS(JCRB)

 

批号：052386：代币/种子（JCRB0086）]
 

  • 从库存中繁殖细胞，传代号052386 
    ， P3 * 
    细胞培养的开始日期： 05/30/86 
    安瓿中细胞的浓度： 7.5×10 ^ 5细胞/ ml 
    显微镜下的存活率（％）： 98％
    使用的抗生素：免费
    支原体，细菌和真菌的检测结果均为阴性。经测试同工酶，AST，G6PD，LD，MD，MPI，NP，PEPB。 

    •  

  •  
  •  
  •  
  •  
  •  

[这批的文化条件。

  • 培养基： 含10％胎牛血清的RPMI1640培养基。传代
    方法： 稀释。
    生长温度： 37 
    细胞编号： 5×10 ^ 5细胞/ ml 
    备注：在安瓿瓶上批号：052386。
    补充说明： 冷冻前的生存力为99％。在10/20/87检查生存力。
批号：071286：分销（JCRB0086）]
 

  • 传代号， P6 * 
    细胞培养的开始日期： 86/07/12 
    细胞浓度： 9×10 ^ 5细胞/ ml 
    使用的抗生素：免费支原体，细菌和真菌的检测均为阴性。经测试同工酶，AST，G6PD，LD，MD，MPI，NP，PEPB。
     

    •  

  •  
  •  
  •  
  •  

[这批的文化条件。

  • 培养基： RPMI1640 + FCS 10％
    通过方法： 稀释。
    生长温度： 37 
    细胞传代数： 5×10 ^ 5细胞/毫升
    其他说明： 确保安培数足够多。

    •  

  •  
  •  
  •  
  •  

[附加数据]

 

    （下载日期： 2008-06-13）

     

    [批号：111787：分销（JCRB0086）]
     

    • 通道号， P5 * 
      细胞培养的开始日期： 11/17/87 
      安瓿中细胞的浓度： 2.8×10 ^ 6细胞/ ml 
      使用的抗生素：免费支原体，细菌和真菌的检测均为阴性。经测试的同工酶，G6PD，LD，NP。
       

      •  

    •  
    •  
    •  
    •  

    [这批的文化条件。

    • 培养基： RPMI1640 + FCS 10％
      通过方法： 稀释。
      生长温度： 37 
      细胞数： 5×10 ^ 5细胞/ ml 
      附加说明： 冷冻前活力为84％。

      •  

    •  
    •  
    •  
    •  

    [附加数据]

     

      （下载日期： 2008-06-13）

       

      [批号：062994：分销（JCRB0086）]
       

      • 传代号， P6 * 
        开始细胞培养，无需克隆之前的库存。
        开始细胞培养的日期： 94/08/94 
        安瓿中细胞的浓度： 1.02×10 ^ 7细胞/ ml 
        生长速率： 36.2小时
        显微镜下生存力（％）： 79.6 
        使用的抗生素：免费
        支原体，细菌和真菌的检测负。经测试的同工酶，G6PD（typeB），LDH，NP。锚固依赖性：无小区标识：可用 
         

        •  

      •  
      •  
      •  
      •  

      [这批的文化条件。

      • 培养基： 含有10％热灭活胎牛血清的RPMI1640培养基（JR Scientific，CO19407）。传代
        方法： 简单稀释法。
        生长温度： 37 C传代
        细胞数： 1.3×10 ^ 5细胞/ ml

        •  

      •  
      •  
      •  
      •  

      [附加数据]

       

      STR-PCR（1），

      •  STR-PCR（2），

      （下载日期： 2008-06-13）

      从cellroot.dbf和cellspec.dbf导出。

      参考文献

      1. 肯塔基州小川市，柴田市，田野清洲，伊野口市，Y。岸田，石本市和安达市。人类免疫缺陷病毒vpr开放阅读框的变异分析， J。Virol。，63：4110-4114，1989。

       

      • 注意：通过重组DNA技术将突变引入人免疫缺陷病毒1型传染性分子克隆的vpr开放阅读框。在几种人类CD4 +淋巴细胞细胞系中研究了这些变化对从转染细胞中重新整合的病毒的复制和细胞病理学特性的影响。在所有情况下，突变病毒均具有传染性和细胞致病性。但是，当使用低投入剂量时，突变体的生长速度明显快于野生型病毒。vpr突变体的生长动力学不同于vif和vpu突变体。
        参考编号：710

         

      2. I. Miyoshi，S. Hiraki，T. Tsubota，T. Kubonishi，I. Matsuda，Y.，Nakayama，T. Kishimoto，H.和Kimura，I. 源自急性淋巴细胞白血病的人B细胞，T细胞和空细胞白血病细胞系，《 自然》，267：843-844，1977。

       

      • 注意：尽管已经从急性和慢性骨髓性白血病和急性淋巴细胞性白血病（ALL）的患者中获得了几种白血病细胞系，但人类白血病细胞的连续培养仍然是一项艰巨的任务。我们在这里描述了从三名ALL患者中新建立的B细胞，T细胞和空细胞白血病细胞系。
        参考ID：1878

         

      3. S. Hiraki，I。Miyoshi，I。Kubonishi，Matsuda，Y。，中山，T.，Kishimoto，H.，Machida，K.，Masuji，H.和Kimura，I。从人淋巴肉瘤建立T细胞系， Gann，69：115-118，1978。

       

      • 注意：在患有T细胞性limphosarcoma白血病的患者的骨骼狭窄处，通过连续培养建立了称为TALL-1的白血病T细胞系。TALL-1细胞具有T细胞特性，缺乏Epstein-Barr病毒或其基因组。根据TALL-1细胞的细胞遗传学，形态学和表面特征，认为它们起源于供体的白血病细胞。
        参考编号：1879

       

      Note Name of Cell Registry No. Animal Tissue Description
        0-9 Page Top      
        104C1 JCRB9036 guinea pig fetal body fetal carcass, benzo(a)pyrene transformed, diploid
        16-8 JCRB0013 mouse antibody-producing hybridoma anti-human erythrocyte, IgM
        19-7 JCRB0014 mouse antibody-producing hybridoma anti-human erythrocyte, IgM
        293 JCRB9068 human kidney transformed embryonal kidney by adenovirus (type5)
        3LL JCRB1348 mouse lung Lewis lung cancer-derived cell line, (C57BL mouse)
        3'-mRLh-2 JCRB0431 rat liver hepatoma, (Donryu rat)
        3'-mRLN-30 JCRB0421 rat liver liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
        3'-mRLN-31 JCRB0422 rat liver liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
        3T3 L1 JCRB9014 mouse embryo fibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
        3T3-L1 IFO50416 mouse embryo fibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
        3T3-Swiss albino IFO50417 mouse embryo fibroblast, contact inhibited, (Swiss albino mouse)
        3T3-Swiss albino JCRB9019 mouse embryo fibroblast, contact inhibited, (Swiss albino mouse)
        3T6-Swiss albino JCRB9059 mouse embryo fibroblast, collagen-secreting, (Swiss albino mouse)
        3Y1-B Clone 1-6 JCRB0734 rat embryo fibroblast, whole embryo, (Fischer 344 rat)
        4-2D JCRB0084 mouse antibody-producing hybridoma anti-primase complexed with DNA polymerase alpha
        4-8H JCRB0083 mouse antibody-producing hybridoma anti-DNA polymerase alpha, IgG1
        4G12 hybridoma IFO50090 mouse x human antibody-producing hybridoma 4G12 antibody, preferentially reacting with lung carcinoma-associated antigen
        5RP7 IFO50277 rat embryo fibroblast transformed by c-Ha-ras oncogene
        6-23 clone 6 IFO50270 rat thyroid medullary thyroid carcinoma, neurotensin and calcitonin-producing, (WAG/RIJ rat)
        77N1 IFO50280 rat kidney transformant of NRK cells by avian sarcoma virus B77, (Osbone-Mendel rat)
        7D4 JCRB9092 mouse x rat antibody-producing hybridoma anti-murine IL-2 receptors (rat antibody)
        8305C JCRB0824 human thyroid thyroid anaplastic carcinoma, undifferentiated
        8505C JCRB0826 human thyroid thyroid carcinoma, undifferentiated
        9-15c JCRB1181 mouse bone marrow mesenchymal cell line
        A Page Top      
        A1 IFO50519 mouse neural derives from p53-deficient mouse brain, used for preparation of conditioned medium for MG5 cells
        A-172 JCRB0228 human neural glioblastoma
        A2058 IFO50276 human melanoma malignant melanoma, metastasis to lymph node
        A2B5 clone 105 IFO50284 mouse antibody-producing hybridoma A2B5 antibody, recognizing a glycolipid expressed in neural tissue
        A3/KAW JCRB0101 human hemo-lymphocytic lymphoma, malignant
        A31-1-1 JCRB1356 mouse embryo fibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
        A31-714 C4 IFO50021 mouse embryo fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
        A4/Fuk JCRB0097 human hemo-lymphocytic lymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing
        A-431 IFO50411 human epidermoid carcinoma epidermoid carcinoma, high expression of EGF receptor
        A-431 JCRB0004 human epidermoid carcinoma epidermoid carcinoma, high expression of EGF-receptor
        A-431 JCRB9009 human epidermoid carcinoma epidermoid carcinoma, high expression of EGF-receptor
        A549 IFO50153 human lung (cancer) adenocarcinoma
        A549 JCRB0076 human lung (cancer) adenocarcinoma
        A9 JCRB0211 mouse skin skin fibroblast, 8-azaguanine-resistant, (C3H mouse)
        A9(0439)-1 JCRB0732 human chromosome-introduced human chromosomal hybrid contains human chromosome Xpter>Xq26::3p12>3pter
        A9(2621)-4 JCRB0730 human chromosome-introduced human chromosomal hybrid contains human chromosome 12pter>12q24::Xq22>Xqter
        A9(3552)-2 JCRB0731 human chromosome-introduced human chromosomal hybrid contains human chromosome 11pter>11q23::Xq26>Xqter
        A9(3884)-1 JCRB0729 human chromosome-introduced human chromosomal hybrid contains human chromosome 16pter>16q24::Xq26>Xqter
        A9(7151)-3 JCRB0728 human chromosome-introduced human chromosomal hybrid contains human chromosome 17pter>17q11::Xq11>Xqter
        A9(An4)-2 JCRB0727 human chromosome-introduced human chromosomal hybrid contains human chromosome # 1
        A9(Bsr10) JCRB2210 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome #10
        A9(BsrX) JCRB2223 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome X
      *8) A9(Hygro13) JCRB2213 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome #13
      *8) A9(Hygro14) JCRB2214 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome #14
      *8) A9(Hygro21) JCRB2221 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome #21
      *8) A9(Hygro22) JCRB2222 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome #22
        A9(Neo1) JCRB2201 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome # 1
        A9(neo11) JCRB2211 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome #11
        A9(Neo12) JCRB2212 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome #12
        A9(Neo15) JCRB2215 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome #15
        A9(Neo16) JCRB2216 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome #16
      *8) A9(Neo17) JCRB2217 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome #17
        A9(Neo18) JCRB2218 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome #18
        A9(Neo19) JCRB2219 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome #19
        A9(Neo2) JCRB2202 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome # 2
        A9(Neo20) JCRB2220 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome #20
        A9(Neo3) JCRB2203 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome # 3
        A9(Neo4) JCRB2204 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome # 4
        A9(Neo5) JCRB2205 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome # 5
        A9(Neo6) JCRB2206 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome # 6
        A9(Neo7) JCRB2207 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome # 7
        A9(Neo8) JCRB2208 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome # 8
        A9(NTI8)-2 JCRB0726 human chromosome-introduced human chromosomal hybrid contains human chromosome # 7
        ABC-1 JCRB0815 human lung (cancer) adenocarcinoma
        Ac2F JCRB0408 rat liver normal liver, diploid, (Donryu rat)
        Ac2F(DT) JCRB0416 rat liver Ac2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat)
        Ac2F(ST) JCRB0417 rat liver Ac2F-derived, spontaneously transformed, (Donryu rat)
        Ad12-3Y1-Z19 JCRB0737 rat embryo 3Y1 derivative, Ad12-transformed, (Fischer rat)
        AH601(JTC27) JCRB0132.1 rat liver transplantable ascites hepatoma, (Donryu rat)
        AH601.P3(JTC27) JCRB0132.2 rat liver transplantable ascites hepatoma, serum-free, (Donryu rat)
        AH601.P3(JTC27) JCRB0132.3 rat liver transplantable ascites hepatoma, serum-free, direct deposition by original developer. (Donryu rat)
        AH66tc JCRB0411 rat liver ascites hepatoma, (Donryu rat)
        AH70Btc JCRB0412 rat liver ascites hepatoma, (Donryu rat)
        AH-7974.P3 JCRB0714.1 rat liver ascites hepatoma, JTC-16 (AH-7974) derivative, serum-free, deposited by original developer, (Donryu rat)
        AIG JCRB1105 hamster, Chinese lung anchorage-independent mutant of CHL
        Alexander cells IFO50069 human liver, gallbladder hepatoma, HBs antigen-positive
        AM-38 IFO50492 human neural glioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-sensitive
        AP-16 IFO50424 mouse neural astrocyte-progenitor cell line, (C3H/He mouse)
        AR-EcoScreen JCRB1328 hamster, Chinese ovary androgen receptor-luciferase reporter gene introduced CHO for reporter assay of androgen (MTA to developer is required)
        ARLJ301-3 JCRB0248 rat liver liver epithelial cell, (F344/DuCrj rat)
        ASF-4-1 IFO50418 human skin skin, normal diploid fibroblast
        ASF-4-2 IFO50419 human skin skin, normal diploid fibroblast
        ASH-3 JCRB1073 human thyroid thyroid anaplastic carcinoma
      *2) AT(L)5KY JCRB0331 human hemo-lymphocytic EBV transformed B lymphoblastoid cell line, ataxia telangiectasia
      *2) AT(L)6KY JCRB0332 human hemo-lymphocytic EBV transformed B lymphoblastoid cell line, ataxia telangiectasia
      *2) AT(L)7KY JCRB0333 human hemo-lymphocytic EBV transformed B lymphoblastoid cell line, ataxia telangiectasia
      *2) AT1OS JCRB0308 human skin ataxia telangiectasia, fibroblast
      *2) AT2KY JCRB0316 human skin ataxia telangiectasia, fibroblast
        AtT-20 JCRB9098 mouse pituitary pituitary tumor, ACTH producing, (LAF1 mouse)
        AZ-521 JCRB0061 human stomach originally established as gastric cancer-derived cell line, but is revealed to be the derivative of duodenum carcinoma cell line HuTu 80
        B Page Top      
        B-1 JCRB0243 mouse testis Leydig cell tumor, estrogen-dependent, (BALB/c mouse)
        B104 JCRB0117 human hemo-lymphocytic lymphoma, malignant B lymphoma
      *1) B104-R3 JCRB0117.1 human hemo-lymphocytic lymphoma, malignant B lymphoma, anti-IgM antibody resistant B104
        B16 melanoma JCRB0202 mouse melanoma melanoma, skin, melanin pigment production (but large portion of cells is amelanotic)., (C57BL/6 mouse)
        B2-17 IFO50361 human neural astrocytoma, thymidine kinase-deficient mutant of U251 MG cells
        B8/3 JCRB0238 mouse hemo-lymphocytic erythroleukemia
        B82 JCRB0212 mouse skin skin fibroblast, bromodeoxyuridine-resistant
        B95-8 JCRB9123 cotten-top tamarin hemo-lymphocytic EBV transformed, release EBV infectious to primates
        BALB/3T3 A31-1-1 JCRB0601 mouse embryo fibroblast, contact inhibited, (BALB/c mouse)
        BALB/3T3 clone A31 JCRB9005 mouse embryo fibroblast, contact inhibited, (BALB/c mouse)
        Balb/3T3-A31-1-1 IFO50070 mouse embryo fibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
        Balb/c 3T3 A31-1-13 IFO50299 mouse embryo fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
        Balb/c 3T3 A31-I-1 IFO50298 mouse embryo fibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
        BALB-MC JCRB0233.0 mouse mammary mammary cancer, (BALB/cHe mouse)
        BALB-MC.D3 JCRB0233.1 mouse mammary mammary cancer, (BALB/cHe mouse)
        BALB-MC.E12 JCRB0233.2 mouse mammary mammary cancer, (BALB/cHe mouse)
        BALL-1 JCRB0071 human hemo-lymphocytic leukemia, acute lymphoblastoid
        BCE C/D-1b JCRB9129 bovine cornea normal corneal epithelial cell, production of extracellular matrix proteins
        BCL1 Clone CW13.20 JCRB9117 mouse hemo-lymphocytic leukemia, B cell, (BALB/c mouse)
      *2) BCNS1KO JCRB0324 human skin basal cell nevus syndrome, fibroblasts
        Becker IFO50289 human neural astrocytoma, GFAP-negative
        BeWo JCRB9111 human placenta chorio carcinoma, trophoblastic cell line
        Bhas 42 JCRB0149 mouse embryo H-ras transfected BALB 3T3 A31-1-1, (BALB/c mouse)
        BHK-21(C-13) JCRB9020 hamster, Syrian kidney kidney, subclone of BHK-21
        BOKU IFO50323 human uterine cervix cervical squamous cell carcinoma
        BRL-3A JCRB0025 rat liver MSA (somatomedin-like) protein producing, (Buffalo rat)
        BRL-3A JCRB9114 rat liver MSA (somatomedin-like) protein producing, (Buffalo rat)
      *2) BS2CH JCRB0317 human skin Bloom's syndrome, fibroblast
        BS2CHTERT JCRB1061 human skin Bloom's syndrome, fibroblast, immortalized by hTERT
        BS-C-1 IFO50413 monkey, African green kidney suitable host for transfection experiments of SV40 vectors
      *1) BS-C-1 JCRB9011 monkey, African green kidney kidney
        BS-C-1 JCRB9126 monkey, African green kidney suitable host for transfection experiments of SV40 vectors
        BSL2KA JCRB1042 human hemo-lymphocytic EBV transformed B lymphoblastoid cell line from Bloom's syndrome patient
        BW5147.G.1.4.OUA-R.1 JCRB9002 mouse hemo-lymphocytic lymphoma, T cell lymphoma, (AKR/J mouse)
        C Page Top      
        C32TG JCRB0227 human melanoma skin amelanotic melanoma, 6-thioguanine-resistant
      *1) C3H/10T1/2 clone 8 JCRB0602 mouse embryo fibroblast, contact inhibited, (C3H mouse)(Now not available. Please use JCRB0003.)
        C3H/10T1/2 clone 8 JCRB9080 mouse embryo fibroblast, contact inhibited, (C3H mouse)
        C3H/10T1/2-clone 8 JCRB0003 mouse embryo fibroblast, contact inhibited, (C3H mouse)
        C3H/10T1/2-clone8 IFO50415 mouse embryo fibroblast, contact inhibited, (C3H mouse)
        C3H/MCA clone 15 IFO50042 mouse embryo 3-methylcholanthrene-transformed C3H/10T1/2, (C3H mouse)
        C6 IFO50110 rat neural glial tumor, GFAP-positive
        C6 JCRB9096 rat neural glial tumor, GFAP-positive
        C6/36 IFO50010 mosquito hatched larvae useful for replication of flavivirus
        C6-SF2 IFO50425 rat neural C6 subline adapted to serum-free medium
        Ca Ski IFO50007 human uterine cervix cervical epidermoid cancer
        Ca9-22 JCRB0625 human oral squamous carcinoma, gingiva
        Caki-1 JCRB0801 human kidney renal clear cell carcinoma
        CaR-1 JCRB0207 human rectum adenocarcinoma
      *1) CCD 841 CoN IFO50482 human colon established from normal colonic tissue, epithelial-like, (distribution finished)
        CCD-14Br JCRB9101 human lung bronchus, diploid
        CCD-33Co IFO50483 human colon established from normal colon, fibroblast, (the lot in cellbank does not grow)
        CCK-81 JCRB0208 human colon adenocarcinoma
        CCRF S-180 II JCRB9089 mouse sarcoma S-180 sarcoma derivative
        CCRF-CEM IFO50412 human hemo-lymphocytic leukemia, acute T lymphoblastic
        CCRF-CEM JCRB0033 human hemo-lymphocytic leukemia, acute T lymphoblastic
        CCRF-CEM JCRB9023 human hemo-lymphocytic leukemia, acute T lymphoblastic
        CCRF-HSB2 JCRB0031 human hemo-lymphocytic leukemia, acute T lymphoblastic
        CCRF-SB IFO50026 human hemo-lymphocytic leukemia, acute B lymphoblastic
        CCRF-SB JCRB0032 human hemo-lymphocytic leukemia, acute B lymphoblastic
        Ch 1 Es JCRB9037 goat esophagus esophagus
        Chang Liver IFO50016 human HeLa-contaminant originally established from liver, HeLa-contaminated
        Chang Liver JCRB9066 human HeLa-contaminant originally established from liver, HeLa-contaminated
        CHL/IU JCRB0030 hamster, Chinese lung normal
      *8) CHO(His9) JCRB2209 human chromosome-introduced human monochromosomal hybrid panel contains human chromosome # 9
        CHO(pMAM-HSluc) JCRB0136.2 hamster, Chinese ovary pMAM-HSluc transfected CHO-K1, HSP 70B gene promoter and luciferase reporter gene introduced
        CHO(pMAM-luc) JCRB0136.1 hamster, Chinese ovary pMAM-luc transfected CHO-K1, luciferase activated by dexamethasone
        CHO/HGPRT JCRB0218 hamster, Chinese ovary HPRT-deficient CHO cell line
        CHO-K1 IFO50414 hamster, Chinese ovary subclone of CHO (Chainese hamster ovary) cells
        CHO-K1 JCRB9018 hamster, Chinese ovary subclone of CHO (Chainese hamster ovary) cells
        CKT-1 IFO50003 bovine kidney useful to assay bovine adenovirus 3
        CKT-1 JCRB0008 bovine kidney useful to assay bovine adenovirus 3
        CMK-11-5 IFO50430 human hemo-lymphocytic leukemia, acute megakaryoblastic
        CMK-86 IFO50428 human hemo-lymphocytic leukemia, acute megakaryoblastic
        CoCM-1 JCRB0257 human colon adenocarcinoma
        COLO201 JCRB0226 human colon adenocarcinoma
        COLO320 DM JCRB0225 human colon adenocarcinoma
        COS-1 JCRB9082 monkey, African green kidney SV40 transformed African green monkey kidney
        COS-7 IFO50068 monkey, African green kidney transformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
        COS-7 JCRB9127 monkey, African green kidney transformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
      *1) CPA IFO50272 bovine vascular system pulmonary artery normal endothelial cell
        CPA JCRB9025 bovine vascular system pulmonary artery normal endothelial cell
        CPAE JCRB9022 bovine vascular system pulmonary artery normal endothelial cell
        CPT-K5 JCRB1067 human hemo-lymphocytic leukemia, acute lymphoblastic, camptothecin-resistant mutant of RPMI8402
        CRFK JCRB9035 cat kidney kidney, BVD antigen negative
        cs-17-25 JCRB1102 hamster, Chinese lung cold-sensitive anchorage-independent growth mutant of CHL
        cs-19-36 JCRB1103 hamster, Chinese lung cold-sensitive anchorage-independent growth mutant of CHL
        cs-20-5 JCRB1104 hamster, Chinese lung cold-sensitive anchorage-independent growth mutant of CHL
      *2) CS2AW JCRB0310 human skin Cockayne's syndrome, fibroblast
        CS2AWTERT JCRB1059 human skin Cockayne's syndrome, fibroblast, immortalized by hTERT
      *2) CS2OS JCRB0309 human skin Cockayne's syndrome, fibroblast
        CS2OS(SVT) JCRB1056 human skin Cockayne's syndrome, fibroblast, immortalized by SV40 large T
        CV-1 JCRB9049 monkey, African green kidney kidney, highly susceptible to SV40 infection
        c-WRT-7-LR JCRB0168 rat hemo-lymphocytic RLV infected myelomonocytic leukemia.
        D Page Top      
      *1) D422T JCRB9112 human sarcoma benign abdominal desmoid tumor
        Daudi JCRB9071 human hemo-lymphocytic lymphoma, Burkitt's
        DBC1.2 IFO50484 mouse olfactory epithelium dark (horizontal) basal cell-like, keratin-positive, (C3H/He mouse)
        DD-762 JCRB1077 mouse mammary mammary tumor, producing MuMTV, (DD/Tbr mouse)
        De Gin JCRB9078 human skin osteoporosis, skin
        delta-47 JCRB1344 human hemo-lymphocytic myeloma, secreting IgD
      *1) Dempsey JCRB9088 human skin Klinefelter's syndrome, skin
        Detroit 510 JCRB9104 human skin galactosemia, skin
        Detroit 525 JCRB9102 human skin Turner's syndrome, skin
      *1) Detroit 529 JCRB9043 human skin Down's syndrome, skin
        Detroit 532 JCRB9044 human skin Down's syndrome, foreskin
        Detroit 539 JCRB9045 human skin Down's syndrome, skin
        DIG104.10H.1 JCRB1213.3 mouse antibody-producing hybridoma anti-digoxin antibody, subclass IgG1(k)
        DIG222.4D.5 JCRB1213.2 mouse antibody-producing hybridoma anti-digoxin antibody, subclass IgG2b(k)
        DL-40 JCRB1337 human hemo-lymphocytic lymphoma, non-Hodikin's, Ki-1-positive
        DLD-1 JCRB9094 human colon adenocarcinoma
        dRLa-74 Clone 2 JCRB0409 rat liver liver adenoma, (Donryu rat)
        dRLh-84 JCRB0410 rat liver hepatoma, (Donryu rat)
        dRLN-4 JCRB0418 rat liver liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
        dRLN-6 JCRB0420 rat liver liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
        dRLN-9 JCRB0419 rat liver liver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
        DSPT200 JCRB0217 hamster, Syrian embryo fetus fibroblast transformed cell
        DT40 JCRB9130 chicken hemo-lymphocytic avian leukosis virus (ALV)-induced lymphomas
        E Page Top      
        E1A-3Y1-1 JCRB0738 rat embryo 3Y1 derivative, transformed by E1A of Ad12 virus, (Fischer rat)
      *1) EB-3 IFO50028 human hemo-lymphocytic eliminated from catalog (IFO50028 EB-3 revealed to be the same as Daudi cell line)
        EBC-1 JCRB0820 human lung (cancer) squamous cell carcinoma
        EBTr (NBL-4) JCRB9038 bovine lung embryonic trachea
      *5) ECV304 JCRB0744 human vascular system immortalized normal endothelium, contamination by T-24/EJ1 was suspected.
        EGV-4T JCRB0229 rat lung immortal cell line from MNNG-transformed tracheal epithelial cells
        Ehrlich ascites JCRB9090 mouse ascites Ehrlich-Lettre ascites carcinoma
        EHS IFO50268 mouse sarcoma chondrosarcoma, secreting basement membrane matrix, (ST/Eh mouse)
        EJ-1 JCRB0710 human bladder bladder carcinoma, contamination by T24 cells has been suspected
        Ex-3LL JCRB1349 mouse lung Lewis lung cancer-derived. Enhanced lung metastasis ability. (C57BL mouse)
        F Page Top      
        F119 JCRB1324 mouse antibody-producing hybridoma anti-CD307 (IRTA2/FcRH5/FCRL5), IgG2b
        F2408 IFO50015 rat embryo fibroblast-like, (Fischer rat)
        F2408 EBNA2 cl-14 JCRB0143.5 rat embryo EBNA2-transfected, (Fischer rat)
        F2408 EBNA2 cl-16 JCRB0143.2 rat embryo EBNA2-transfected, (Fischer rat)
        F2408 EBNA2 cl-18 JCRB0143.3 rat embryo EBNA2-transfected, (Fischer rat)
        F2408 EBNA2 cl-23 JCRB0143.6 rat embryo EBNA2-transfected, (Fischer rat)
        F2408 EBNA2 cl-24 JCRB0143.4 rat embryo EBNA2-transfected, (Fischer rat)
        F2408 EBNA2 cl-28 JCRB0143.7 rat embryo EBNA2-transfected, (Fischer rat)
        F2408 EBNA2 cl-9 JCRB0143.1 rat embryo EBNA2-transfected, (Fischer rat)
        F2408 pZipNeo JCRB0143.0 rat embryo pZipNeo-transfected, control for F2408 EBNA2 clones, (Fischer rat)
        F2408-B812 IFO50099 rat embryo HGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
        F2408-B993 IFO50100 rat embryo HGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
        F2408-No.20 IFO50101 rat embryo thymidine kinase-deficient F2408 cell line, (Fischer rat)
        F2408-No.3 IFO50098 rat embryo HGPRT-deficient F2408 cell line, (Fischer rat)
        F2408-No.7 IFO50102 rat embryo HGPRT-deficient F2408 cell line, (Fischer rat)
        F25 JCRB1323 mouse antibody-producing hybridoma anti-CD307 (IRTA2/FcRH5/FCRL5), IgG2a
        F56 JCRB1189 mouse antibody-producing hybridoma anti-CD307 (IRTA2/FcRH5/FCRL5), IgG1
        F9 JCRB0721 mouse teratoma teratocarcinoma, differentiation-inducible, (129/Sv mouse)
        F9-41 JCRB0001 mouse teratoma teratocarcinoma, differentiation-inducible, (129/Sv mouse)
      *2) FA18JTO JCRB0315 human skin Fanconi's anemia, fibroblast
      *2) FA9JTO JCRB0314 human skin Fanconi's anemia, fibroblast
        FA9JTOTERT JCRB1060 human skin Fanconi's anemia, fibroblast, immortalized by hTERT
        FAA-HTC1 JCRB0249 rat liver hepatocellular carcinoma, 2-acetylaminofluorene induced, (F344/DuCrj rat)
        FBHE IFO50154 bovine vascular system heart normal endothelial cell, FGF-dependent for survival
        FF101 JCRB1040 rat liver hepatoma, 3'-methyl-4-dimethylaminoazobenzene-induced, serum-free, (Donryu rat)
        FHs 74 Int JCRB9076 human intestine fetal small intestine, normal, (not intestinal epithelial cell)
      *1) FL* JCRB9016 human HeLa-contaminant originally established from amnion, HeLa-contaminated
        FLAM-76 JCRB1346 human hemo-lymphocytic myeloma, IL-6-dependent, growth is very slow
        Flow2000 IFO50089 human lung fetal lung, normal diploid fibroblast
      *1) Flow2000 JCRB0067 human lung fetal lung, normal diploid fibroblast (not available)
        Flow3000 JCRB0068 human neural normal fibroblast
        Flow7000 IFO50079 human skin skin, normal diploid fibroblast
        FLS3 IFO50377 mouse liver liver stromal cell line
        FLS5 IFO50378 mouse liver liver stromal cell line
        FM3A JCRB0701 mouse mammary mammary carcinoma, spontaneously obtained, (C3H/He mouse)
        FM3A APRT~ JCRB0703 mouse mammary mammary carcinoma, APRT-deficient FM3A, (C3H/He mouse)
        FM3A HPRT~ JCRB0702 mouse mammary mammary carcinoma, HPRT-deficient FM3A , (C3H/He mouse)
        FM3A TK~ JCRB0704 mouse mammary mammary carcinoma, thymidine kinase-deficient FM3A, (C3H/He mouse)
      *2) FPC15JTO JCRB0319 human skin familial polyposis coli, fibroblasts
      *2) FPC5JTO JCRB0318 human skin familial polyposis coli, fibroblasts
        FRSK JCRB0005 rat skin epidermal keratinocyte line from fetal skin
        FS-1 IFO50477 human bone marrow stroma bone marrow stromal cell from a myelogenous leukemia patient
        FSthy21 JCRB0719 mouse thymidylate defective complete defective strain of thymidylate synthase, (C3H mouse)
        FU97 JCRB1074 human stomach adenocarcinoma, poorly differentiated, AFP producing
        G Page Top      
        G-292 clone A141B1 IFO50107 human sarcoma osteosarcoma
        G-361 IFO50009 human melanoma malignant melanoma, skin
        G-361 JCRB9074 human melanoma malignant melanoma, skin
        G-401 JCRB9065 human kidney Wilms' tumor (embryonal carcinosarcoma of kidney)
        G-402 JCRB9070 human kidney renal leiomyoblastoma
        GAK IFO50321 human melanoma malignant melanoma at external genitalia, metastasis to lymph node
        GAK JCRB0180 human melanoma malignant melanoma at external genitalia, metastasis to lymph node
        GB-1 IFO50489 human neural glioma, GFAP, vimentin and fibronectin-positive
        GCH-nu-YS JCRB1201 human uterus gestational uterine choriocarcinoma
        GH1 IFO50269 rat pituitary pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
        GH1 JCRB9046 rat pituitary pituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
        GH3 IFO50105 rat pituitary pituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
        GH3 JCRB9047 rat pituitary pituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
        GHBP116 JCRB1226 mouse antibody-producing hybridoma anti-human growth hormone receptor antibody-producing, subclass IgG1(k)
        GOTO JCRB0612 human neural neuroblastoma, adrenal gland
        GOTO.P3 JCRB0612.1 human neural neuroblastoma, adrenal gland, serum-free
      *2) GP-1 JCRB1366 guinea pig hemo-lymphocytic Guinea pig leukocyte line co-infected with HTLV-I and HTLV-II. (This cell line is supplied from National Institute of Biomedical Innovation.)
        GP8 JCRB1198 mouse skin human beta-galactosidase gene introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
        GRSL IFO50111 mouse hemo-lymphocytic thymic leukemia, (GR/A mouse)
      *2) GS33JTO JCRB0322 human skin Gardner's syndrome, fibroblasts, (M)
      *2) GS7OJTO JCRB0323 human skin Gardner's syndrome, fibroblasts
        H Page Top      
        HARA JCRB1080.0 human lung (cancer) squamous carcinoma, PTHrP producing
        HARA-B JCRB1080.1 human lung (cancer) squamous carcinoma, PTHrP producing, established from nude mouse bone metastasis of HARA cells
        HCA-1 JCRB1153 human uterine cervix endocervical adenocarcinoma endocervical adenocarcinoma cell line.
      *4) HCC-56 JCRB1037 human colon adenocarcinoma, moderately differentiated
        HCS-2 JCRB1203 human uterine cervix cervical squamous cell carcinoma
        HCSC-1 JCRB1205 human uterine cervix endocervical small cell carcinoma
      *2) HCT-2 JCRB1362 hamster, Syrian hemo-lymphocytic Hamster spleen lymphocytes transformed by HTLV-I (This cell line is supplied from National Institute of Biomedical Innovation).
        HD-70 JCRB1335 human hemo-lymphocytic lymphoma, from Hodgkin's
        HE-1 IFO50297 human embryo whole fetus, normal diploid fibroblast
        HEC-1 JCRB0042 human uterus endometrial adenocarcinoma
        HEC-108 JCRB1123 human uterus endometrial adenocarcinoma
        HEC-116 JCRB1124 human uterus endometrial adenocarcinoma
        HEC-151 JCRB1122 human uterus endometrial adenocarcinoma
      *5) HEC-155 JCRB1127 human uterus endometrial adenocarcinoma, (distribution was suspended)
        HEC-1-A JCRB1117 human uterus endometrial adenocarcinoma
        HEC-1-B JCRB1193 human uterus endometrial adenocarcinoma
        HEC-251 JCRB1141 human uterus endometrial adenocarcinoma
        HEC-265 JCRB1142 human uterus endometrial adenocarcinoma
        HEC-50B JCRB1145 human uterus endometrial adenocarcinoma
        HEC-59 JCRB1120 human uterus endometrial adenocarcinoma
        HEC-6 JCRB1118 human uterus endometrial adenocarcinoma
        HEC-88nu JCRB1121 human uterus endometrial adenocarcinoma
        HEL JCRB0062 human hemo-lymphocytic leukemia, erythroid
        HeLa JCRB9004 human uterine cervix epitheloid carcinoma
        HeLa 229 JCRB9086 human uterine cervix epitheloid carcinoma
        HeLa AG JCRB0213 human uterine cervix epitheloid carcinoma, 8-azaguanine-resistant
        HeLa S3 IFO50011 human uterine cervix cervical epithelioid carcinoma
        HeLa S3 JCRB9010 human uterine cervix cervical epitheloid carcinoma, adaptable to a suspension culture
        HeLa S3 (sc) JCRB0713 human uterine cervix HeLa derivative, can grow in suspension culture
        HeLa TG JCRB0214 human uterine cervix epitheloid carcinoma, 6-thioguanine-resistant
        HeLa TG Cap JCRB0215 human uterine cervix epitheloid carcinoma, 6-thioguanine, chloramphenicol-resistant
        HeLa.P3 JCRB0649 human uterine cervix serum free adapted HeLa cell line
        HeLa.P3 JCRB0649.1 human uterine cervix serum free adapted HeLa cell line, deposited by original developer
        HeLa.P3(S) JCRB0606 human uterine cervix HeLa cell derived, can grow in a serum-free medium
        HeLa9903 JCRB1318 human uterine cervix hERalpha-HeLa-9903, transfected with estrogen receptor-alpha – reporter gene construct. (MTA to developer is required)
        Hep G2 JCRB1054 human liver, gallbladder hepatoma
        HEPM JCRB9095 human oral embryonic palatal mesenchyme, limited life span
        HFb16d JCRB1008 human skin normal fibroblast transfected with HPV16
        HFL1 IFO50074 human lung fetal lung, normal diploid fibroblast
        HGH1.1.3 JCRB1222.01 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG1(k)
        HGH1.11.1 JCRB1222.08 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG2b(k)
        HGH1.15.3 JCRB1222.09 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG1(k)
        HGH1.17.2 JCRB1222.03 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG1(k)
        HGH1.31.3 JCRB1222.12 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG1(k)
        HGH1.32.4 JCRB1222.13 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG2b(k)
        HGH1.35.2 JCRB1222.04 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG2a(k)
        HGH1.41.1 JCRB1222.10 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG2b(k)
        HGH1.46.1 JCRB1222.11 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG2b(k)
        HGH1.6.5 JCRB1222.02 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG1(k)
        HGH1.8.1 JCRB1222.07 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG2b(k)
        HGH1.9.3 JCRB1222.06 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG1(k)
        HGH2.15.4 JCRB1222.16 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG1(lambda)
        HGH2.4.2 JCRB1222.15 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG1(k)
        HGH2.6.1 JCRB1222.05 mouse antibody-producing hybridoma anti-human growth hormone antibody, subclass IgG1(k)
        HH JCRB0099 bovine vascular system carotid artery normal endothelial cell
        HKA-1 JCRB1017 human skin giant keratoacanthoma
        HL60 JCRB0085 human hemo-lymphocytic leukemia, acute promyelotic, differentiation-inducible
        HL-60 IFO50022 human hemo-lymphocytic leukemia, acute promyelocytic, Ability for the differentiation by TPA or DMSO reduced
        HL60(S) JCRB0163 human hemo-lymphocytic leukemia, acute promyelotic
        HL60RG JCRB0006 human hemo-lymphocytic leukemia, acute promyelocytic, HL60-derived, equivalent to IFO50022, Ability for the differentiation by TPA or DMSO reduced
        HLCL-1 JCRB0041 human hemo-lymphocytic lymphocyte, peripheral
        HLE JCRB0404 human liver, gallbladder hepatoma, non-differentiated
        HLF JCRB0405 human liver, gallbladder hepatoma, non-differentiated
        HM-1 JCRB1208 hamster, Syrian hemo-lymphocytic macrophage line
        HMC-1-8 JCRB0166 human mammary breast cancer, target cell of the T-cell killer clone T(cHMC-1)
        HMY-1 JCRB1018 human melanoma malignant melanoma, sole, melanin production is poor
        HO-1-N-1 JCRB0831 human oral squamous carcinoma, buccal mucosa
        HO-1-u-1 JCRB0828 human oral squamous carcinoma, mouth floor
        HOS IFO50106 human sarcoma osteosarcoma
        HPSV178-4-3 JCRB1314 mouse antibody-producing hybridoma HPSV178 antibody, against GPI-anchorless splice variant of prion protein
        HR-3Y1-2 JCRB0743 rat embryo 3Y1 derivative, transformed by v-H-ras cDNA, (Fischer rat)
        hs-103-3 JCRB1096 hamster, Chinese lung heat-sensitive anchorage-independent growth mutant of CHL
        hs-164-2 JCRB1097 hamster, Chinese lung heat-sensitive anchorage-independent growth mutant of CHL
        hs-171-1 JCRB1098 hamster, Chinese lung heat-sensitive anchorage-independent growth mutant of CHL
        hs-172-3 JCRB1099 hamster, Chinese lung heat-sensitive anchorage-independent growth mutant of CHL
        hs-211 JCRB1100 hamster, Chinese lung heat-sensitive anchorage-independent growth mutant of CHL
        HS-22 JCRB1215 mouse bone marrow mesenchymal stem cell line
        hs-222-3 JCRB1101 hamster, Chinese lung heat-sensitive anchorage-independent growth mutant of CHL
        Hs68 IFO50350 human skin skin, normal diploid fibroblast
        HSC-1 JCRB1015 human skin squamous carcinoma
        HSC-2 JCRB0622 human oral squamous carcinoma, mouth
        HSC-3 JCRB0623 human oral squamous carcinoma, tongue
        HSC-4 JCRB0624 human oral squamous carcinoma, tongue
        HSC-5 JCRB1016 human skin squamous carcinoma
        HSC-F JCRB1164 monkey, Cynomolgus hemo-lymphocytic HSV-immortalized T-cell line, susceptible to SIV
        HSGc-C5 JCRB1070 human HeLa-contaminant originally established from salivary gland, Hela-contaminated, used as a standardization for the heavy particle irradiation.
        HSP-239 JCRB1165 chimpanzee hemo-lymphocytic peripheral blood lymphocyte line immortalized with Herpesvirus saimiri
        HSP-250 JCRB1177 chimpanzee hemo-lymphocytic peripheral blood lymphocyte line immortalized with Herpesvirus saimiri
        HSR-5 JCRB1211 monkey, rhesus hemo-lymphocytic peripheral blood lymphocyte line immortalized with Herpesvirus saimiri
        HS-Sultan JCRB9062 human hemo-lymphocytic established as plasmacytoma, but revealed as derivative of Jiyoye cell line (Burkitt's lymphoma)
        HT100 JCRB0221 hamster, Syrian lung lung, new born
        HT-1080 IFO50354 human sarcoma fibrosarcoma, acetabulum
        HT-1080 JCRB9113 human sarcoma fibrosarcoma, acetabulum
        HTC/C3 JCRB0164 human thyroid thyroid carcinoma
        HuCCT1 JCRB0425 human liver, gallbladder bile duct carcinoma
      *8) huH-1 JCRB0199 human liver, gallbladder hepatoma, HBs antigen-positive, HBc(-), HBe(-).
        HuH28 JCRB0426 human liver, gallbladder bile duct carcinoma
        HUH-6 Clone 5 JCRB0401 human liver, gallbladder hepatoblastoma, well differentiated
        HuH-7 JCRB0403 human liver, gallbladder hepatoma, differentiated
      *1) Human Mucosal cells JCRB9116 human colon colon
        HuO-3N1 JCRB0413 human sarcoma osteosarcoma, ilium
        HuO9 JCRB0427 human sarcoma osteosarcoma
        HuO9N2 JCRB0428 human sarcoma osteosarcoma
        HUV-EC-C IFO50271 human vascular system normal endothelial cell, umbilical cord
        I Page Top      
        I-10 JCRB9097 mouse testis Leydig cell testicular tumor (BALB/cJ mouse)
        I51T JCRB1225 mouse skin deficient human beta-gal introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
        IAR-20 JCRB0610 rat liver non-transformed live cell line, (BD-IV rat)
        IHH-4 JCRB1079 human thyroid thyroid anaplastic carcinoma, (exhibits the same DNA profile as TMH-1.)
        IM-9 IFO50025 human hemo-lymphocytic myeloma, multiple, B lymphoblastic
        IM-9 JCRB0024 human hemo-lymphocytic myeloma, multiple, B lymphoblastic
        IM95 JCRB1075.0 human stomach adenocarcinoma, moderately differentiated
        IM95m JCRB1075.1 human stomach adenocarcinoma, moderately differentiated, an IM95 clone producing higher level of HGF & VEGF
        IMR-32 IFO50283 human neural neuroblastoma
        IMR-32 JCRB9050 human neural neuroblastoma
      *4) IMR-90 JCRB0516 human lung fetal lung, normal diploid fibroblast
        IMR-90 JCRB9054 human lung fetal lung, normal diploid fibroblast
        IMR-90-40 JCRB0519 human lung fetal lung, normal diploid fibroblast, PDL=about 40
      *3) IMR-90-50 JCRB0520 human lung fetal lung, normal diploid fibroblast, PDL=about 50
        Indian Muntjac JCRB9100 Indian Muntjak skin used for chromosomal study
        IT-26R21 IFO50078 rat thymus T cell differentiation factor producing, (Wistar rat)
        IT-45R1 IFO50076 rat thymus T cell differentiation factor producing, (Wistar rat)
        IT-45R91 IFO50077 rat thymus thymic fibroblast, (Wistar rat)
        IT-79MTNC3 IFO50248 mouse thymus thymic nurse cell, (BALB/c mouse)
        ITO-II JCRB0613 human testis testicular tumor, (embryonal tumor)
        J Page Top      
        J-111 IFO50005 human HeLa-contaminant originally established from acute monocytic leukemia, HeLa-contaminated
        J-111 JCRB0073 human HeLa-contaminant originally established from acute monocytic leukemia, HeLa-contaminated
        J774.1 JCRB0018 mouse hemo-lymphocytic monocyte-macrophage, IL-1-producing, (BALB/c mouse)
        J774A.1 JCRB9108 mouse hemo-lymphocytic monocyte-macrophage, (BALB/c mouse)
      *6) JHH-1 JCRB1062 human liver, gallbladder hepatoma
      *6) JHH-2 JCRB1028 human liver, gallbladder hepatoma
      *6) JHH-4 JCRB0435 human liver, gallbladder hepatoma
      *6) JHH-5 JCRB1029 human liver, gallbladder hepatoma
      *6) JHH-6 JCRB1030 human liver, gallbladder hepatoma
      *6) JHH-7 JCRB1031 human liver, gallbladder hepatoma, HBV-integration
        JKT-beta-del JCRB0147 human hemo-lymphocytic leukemia, T-cell, Jurkat cell clone with a lack of surface expression of T-cell receptor alpha/beta/CD3 complex
        JTC-11 JCRB0424 mouse ascites Ehrlich ascites
        JTC-16 P3 JCRB0714 rat liver ascites hepatoma, JTC-16 derivative, serum-free, (Donryu rat)
        JTC19 JCRB0608 rat lung lung, (JAR-1 rat)
        K Page Top      
        K562 JCRB0019 human hemo-lymphocytic leukemia, chronic myelogenous, differentiation-inducible
        K562/ADM JCRB1002 human hemo-lymphocytic leukemia, chronic myelogenous, adriamycin resistant derivative of K562
        KAI3 IFO50518 human hemo-lymphocytic EBV-infected NK-like cell line, IL-2 dependent
        KALS-1 IFO50434 human neural glioma, GFAP, vimentin and CD13-positive
        Kasumi-1 JCRB1003 human hemo-lymphocytic leukemia, acute myeloid
        Kasumi-3 JCRB1004 human hemo-lymphocytic leukemia, acute myeloperoxidase-negative
        Kasumi-6 JCRB1024 human hemo-lymphocytic leukemia, acute myeloid
        KATOIII JCRB0611 human stomach signet ring cell carcinoma
        KB JCRB9027 human HeLa-contaminant originally established from oral epidermoid carcinoma, HeLa-contaminated
        KCL-22 JCRB1317 human hemo-lymphocytic leukemia, chronic myelocytic, Ph1-positive
        KD JCRB9103 human oral fibroblast, lip
        KG-1 JCRB0065 human hemo-lymphocytic leukemia, acute myeloblastic
        KG-1 JCRB9051 human hemo-lymphocytic leukemia, acute myelogenous
        KG-1-C JCRB0236 human neural mixed glioma, GFAP-negative, S-100-positive
        KHM-10B JCRB0165 human hemo-lymphocytic lymphoma, Burkitt's, ALL-L3 cell line with a 13q34 abnormality, constitutive c-myc, max expression
        KHM-1B JCRB0133 human hemo-lymphocytic myeloma, multiple, with hyperamylasemia.
        KHM-3S JCRB0138 human lung (cancer) small cell carcinoma, HTLV-1gene integration
        KHM-5M JCRB0148 human thyroid thyroid carcinoma, undifferentiated, IL-8 producing
        KHYG-1 JCRB0156 human hemo-lymphocytic leukemia, NK cell-like, IL-2 dependent
        Ki-JK JCRB1065 human hemo-lymphocytic lymphoma, anaplastic giant cell, Ki-1(CD30)-positive
        KINGS-1 IFO50435 human neural astrocytoma, anaplastic, GFAP, S-100, vimentin, CD13 and HNK-1-positive
        KMBC-2 JCRB1148 human bladder urinary bladder carcinoma
        KMH-2 JCRB1066 human thyroid thyroid anaplastic carcinoma
        KML-1 JCRB1347 human hemo-lymphocytic lymphoma, non-Hodgkins
        KMLS-1 JCRB0200 human sarcoma liposarcoma
        KMM-1 JCRB1180 human hemo-lymphocytic myeloma
        KMPC-3 JCRB1150 human kidney cell line derived from renal pelvis
        KMRC-1 JCRB1010 human kidney renal clear cell carcinoma
        KMRC-2 JCRB1011 human kidney renal clear cell carcinoma
        KMRC-20 JCRB1071 human kidney renal cancer
        KMRC-3 JCRB1012 human kidney renal clear cell carcinoma (growth is very slow)
      *4) KMRC-5 JCRB1007 human kidney renal clear cell carcinoma
        KMRM-M1 JCRB1014 human kidney renal carcinoma
        KMS-11 JCRB1179 human hemo-lymphocytic myeloma, multiple, IgG kappa-secreting, EBNA(-)
        KMS-12-BM JCRB0429 human hemo-lymphocytic myeloma, late stage of B-cell differentiation
        KMS-12-PE JCRB0430 human hemo-lymphocytic myeloma, late stage of B-cell differentiation
        KMS-20 JCRB1196 human hemo-lymphocytic myeloma
        KMS-21BM JCRB1185 human hemo-lymphocytic myeloma
        KMS-26 JCRB1187 human hemo-lymphocytic myeloma
        KMS-27 JCRB1188 human hemo-lymphocytic myeloma
        KMS-28BM JCRB1192 human hemo-lymphocytic myeloma
        KMS-28PE JCRB1191 human hemo-lymphocytic myeloma
        KMS-34 JCRB1195 human hemo-lymphocytic myeloma
        KMS-6 JCRB0432 human embryo fibroblast, normal diploid
        KMST-6 JCRB0433 human embryo fibroblast, immortalized by 60Co irradiation, derivative of KMS-6
      *1) KMST-6/T JCRB0434 human embryo fibroblast, immortalized after extensive passages, derivative of KMS-6
        KNS-42 IFO50356 human neural glioma, GFAP-positive, S-100 and NSE-negative
        KNS-60 IFO50357 human neural glioma, GFAP, S-100 and NSE-negative
        KNS-62 IFO50358 human lung (cancer) bronchial squamous carcinoma, metastasis to brain
        KNS-81 IFO50359 human neural glioma, GFAP and S-100-positive, NSE-negative
        KNS-81-FD IFO50444 human neural glioma, derivative of KNS-81 adapted to serum-free medium
      *1) KNS-89 IFO50360 human neural gliosarcoma, GFAP and NSE-positive, S-100-negative (contamination by U-251 MG has been suspected, excluded from catalogue.)
      *5) KO51 JCRB0122 human hemo-lymphocytic leukemia, acute myeloblastic, contamination of K562 has been suspected.
        KO52 JCRB0123 human hemo-lymphocytic leukemia, acute myeloblastic
        KON JCRB0194 human oral squamous carcinoma, mouth, ras P21 expression
        KOSC-2 cl3-43 JCRB0126.1 human oral squamous carcinoma, stage III, oral floor
      *5) KOSC-3 JCRB0127 human oral squamous carcinoma, stage III, lower gingiva, contamination by Ca9-22 was suspected.
      *5) KP-1N JCRB0177.0 human pancreas pancreatic cancer, adenocarcinoma (distribution is suspended)
      *5) KP-1NL JCRB0177.1 human pancreas pancreatic cancer, adenocarcinoma, highly metastatic to liver in nude mice (distribution is suspended)
        KP-2 JCRB0181 human pancreas pancreatic ductal cell carcinoma, moderately differentiated tubular adenocarcinoma
        KP-3 JCRB0178.0 human pancreas pancreatic cancer, adenosquamous carcinoma
        KP-3L JCRB0178.1 human pancreas pancreatic cancer, adenosquamous carcinoma, highly metastatic to liver in nude mice
        KP-4 JCRB0182 human pancreas pacnreatic ductal cell carcinoma, secreting PTHrP
        KP-N-RT-BM-1 IFO50432 human neural neuroblastoma, from bone marrow, neuronal and Schwannian differentiation
        KP-N-SI9s IFO50433 human neural neuroblastoma, from lymph node, smooth muscle marker-expressing
        KP-N-YN IFO50431 human neural neuroblastoma, from lymph node, smooth muscle marker-expressing
        KS-1 IFO50436 human neural glioblastoma
        KT-5 IFO50161 mouse neural astrocyte line, GFAP-positive, (C3H/He mouse)
        KU812 IFO50363 human hemo-lymphocytic leukemia, chronic myeloid
        KU812 JCRB0104 human hemo-lymphocytic leukemia, chronic myeloid
        KU812E JCRB0104.1 human hemo-lymphocytic leukemia, chronic myeloid
        KU812F JCRB0104.2 human hemo-lymphocytic leukemia, chronic myeloid
        KUM10 JCRB1176 mouse bone marrow osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
        KUM3 JCRB1134 mouse bone marrow osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
        KUM4 JCRB1135 mouse bone marrow osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
        KUM5 JCRB1178 mouse bone marrow osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
        KUM6 JCRB1202 mouse bone marrow osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
        KUM7 JCRB1204 mouse bone marrow osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
        KUM9 JCRB1139 mouse bone marrow osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
        KURAMOCHI JCRB0098 human ovary undifferentiated carcinoma, ascites
        KUSA-A1 JCRB1119 mouse bone marrow osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
        KUSA-H1 JCRB1129 mouse bone marrow osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
        KUSA-O JCRB1132 mouse bone marrow osteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
        KY821 JCRB0105 human hemo-lymphocytic leukemia, acute myeloid
        KY821A3 JCRB0105.1 human hemo-lymphocytic leukemia, acute myeloid, subclone of KY821
        KYM-1 JCRB0627 human sarcoma rhabdomyosarcoma, neck
      *6) KYSE110 JCRB1064 human esophagus squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6) KYSE140 JCRB1063 human esophagus squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6) KYSE150 JCRB1095 human esophagus squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6) KYSE170 JCRB1082 human esophagus squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6) KYSE180 JCRB1083 human esophagus squamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6) KYSE220 JCRB1086 human esophagus squamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6) KYSE270 JCRB1087 human esophagus squamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6) KYSE30 JCRB0188 human esophagus squamous carcinoma, well-differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6) KYSE50 JCRB0189 human esophagus squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6) KYSE70 JCRB0190 human esophagus squamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
        L Page Top      
        L alpha JCRB0125 mouse skin L cell line introduced with poliovirus receptor protein alpha gene, thymidine kinase defective
        L cl 1D JCRB0722 mouse skin fibroblast, thymidine kinase-deficient, (C3H mouse)
        L.P3 JCRB0648 mouse skin serum-free adapted L929 cell line
        L.P3(S) JCRB0605 mouse skin L cell derived, can grow in a serum-free medium, (C3H mouse)
        L1210 JCRB9026 mouse hemo-lymphocytic leukemia, lymphocytic, (DBA/2 mouse)
        L-2 JCRB9053 rat lung adult lung
        L2C IFO50210 guinea pig hemo-lymphocytic leukemic cell, maintainable only by transplantation
        L5178Y JCRB0709 mouse hemo-lymphocytic lymphoma, methylcholanthrene induced, (DBA/2 mouse)
        L5178Y TK+/-3.7.2c JCRB0709.1 mouse hemo-lymphocytic L5178Y derivative, thymidine kinase +/- heterozygotic line
        L5178Y ts2 JCRB0723 mouse hemo-lymphocytic L5178Y derivative, abnormal cell division at non-permissive temperature
        L5178Y ts39 JCRB0724 mouse hemo-lymphocytic L5178Y derivative, micronucleation at non-permissive temperature
        L6 IFO50364 rat muscular system skeletal muscle myoblast
        L6 JCRB9081 rat muscular system skeletal muscle myoblast
        L6TG JCRB0209 rat muscular system skeletal muscle myoblast, 6-thioguanine-resistant
        L6TG Cap JCRB0210 rat muscular system skeletal muscle myoblast, 6-thioguanine, chloramphencol-resistant